NDC 62157-920-01 - Prazosin HCl polyhydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62157-920
- Requested NDC
- 62157-920-01
- Package NDCs from labels
- 62157-920-01
- Manufacturer
- AX Pharmaceutical Corp | Nuray Chemicals Private Limited
- Effective date
- 2019-10-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAZOSIN - AX Pharmaceutical Corp | Nuray Chemicals Private Limited | AX Pharmaceutical Corp | Nuray Chemicals Private Limited | 2019-10-16 | BULK INGREDIENT |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Aurobindo Pharma Limited | 08114092-fa12-4f58-b08e-03cadf9f726b | 2023-04-04 | Warnings, Adverse reactions | X0Z7454B90 |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 1a92a503-cf5e-48ef-a6fd-79fe98fdd8a0 | 2023-04-03 | Warnings, Adverse reactions | X0Z7454B90 |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d33bb132-1b5f-44a2-bc42-e9201cb6566a | 2023-03-20 | Warnings, Adverse reactions | X0Z7454B90 |
| prazosin hydrochloride | PRAZOSIN HYDROCHLORIDE | Lifestar Pharma LLC | 73bbc360-5bfb-4139-a63e-0cb6e4ea8313 | 2023-03-17 | Warnings, Adverse reactions | X0Z7454B90 |
| PRAZOSIN HYDROCHLORIDE | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | fea187a3-ee8b-4463-8485-3b1de1504609 | 2023-03-10 | Warnings, Adverse reactions | X0Z7454B90 |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Exelan Pharmaceuticals | cdde7b22-6b29-4cac-8bd6-f613dab6eef1 | 2023-01-26 | Warnings, Adverse reactions | X0Z7454B90 |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 1ce90aaf-d075-4617-9a47-e8d922096d23 | 2022-09-01 | Warnings, Adverse reactions | X0Z7454B90 |
| Prazosin Hydrochloride | PRAZOSIN HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 7293cef3-ef9e-40dc-9995-875ef047f693 | 2018-10-25 | Warnings, Adverse reactions | X0Z7454B90 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.